当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析 - 现金流量表

新华医疗

(600587)

  

流通市值:92.77亿  总市值:93.13亿
流通股本:6.04亿   总股本:6.07亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,543,184,025.824,344,432,565.172,039,406,999.499,654,305,608.68
  收到的税费返还2,761,465.63833,600.1647,045.8314,120,194.1
  收到其他与经营活动有关的现金217,994,965.2153,122,012.4474,295,823.59223,981,826.08
  经营活动现金流入小计6,763,940,456.654,498,388,177.712,114,349,868.919,892,407,628.86
  购买商品、接受劳务支付的现金4,258,430,728.822,722,941,294.841,447,769,448.856,543,048,145.53
  支付给职工以及为职工支付的现金1,280,425,889.34876,189,693.92514,463,946.051,713,941,485.38
  支付的各项税费344,602,000.05222,863,987.8395,992,645.78448,907,317.69
  支付其他与经营活动有关的现金660,818,055.62433,641,951.27219,748,749.51735,777,194.72
  经营活动现金流出小计6,544,276,673.834,255,636,927.862,277,974,790.199,441,674,143.32
  经营活动产生的现金流量净额219,663,782.82242,751,249.85-163,624,921.28450,733,485.54
二、投资活动产生的现金流量:
  收回投资收到的现金12,405,032.461,000,0001,000,000135,229,470.74
  取得投资收益收到的现金6,547,734.086,460,245.86-58,635,209.85
  处置固定资产、无形资产和其他长期资产收回的现金净额1,020,035.751,003,018.85360,733.14238,093.87
  处置子公司及其他营业单位收到的现金净额99,870,479.7599,870,479.75--
  收到的其他与投资活动有关的现金--90,937.4-
  投资活动现金流入小计119,843,282.04108,333,744.461,451,670.54194,102,774.46
  购建固定资产、无形资产和其他长期资产支付的现金298,226,154.22244,852,210.3171,320,582.18420,884,416.89
  投资支付的现金23,944,877.4216,944,877.4216,344,877.4291,923,932.04
  投资活动现金流出小计322,171,031.64261,797,087.72187,665,459.6512,808,348.93
  投资活动产生的现金流量净额-202,327,749.6-153,463,343.26-186,213,789.06-318,705,574.47
三、筹资活动产生的现金流量:
  吸收投资收到的现金---191,464
  其中:子公司吸收少数股东投资收到的现金---191,464
  取得借款收到的现金935,150,000657,500,000454,100,0001,004,590,000
  收到其他与筹资活动有关的现金11,000,00011,000,0001,000,00019,844,972.81
  筹资活动现金流入小计946,150,000668,500,000455,100,0001,024,626,436.81
  偿还债务支付的现金893,137,723.08592,229,500414,414,333.33920,000,000
  分配股利、利润或偿付利息支付的现金198,794,969.2128,776,015.3215,100,877.21340,707,516.23
  其中:子公司支付给少数股东的股利、利润7,484,0006,292,900-11,673,000
  支付其他与筹资活动有关的现金24,141,009.2214,464,963.383,099,949.91171,049,062.22
  筹资活动现金流出小计1,116,073,701.51635,470,478.7432,615,160.451,431,756,578.45
  筹资活动产生的现金流量净额-169,923,701.5133,029,521.322,484,839.55-407,130,141.64
四、汇率变动对现金及现金等价物的影响37,491.42-232,779.97-307,151.034,033,451.87
五、现金及现金等价物净增加额-152,550,176.87122,084,647.92-327,661,021.82-271,068,778.7
  加:期初现金及现金等价物余额2,769,762,941.022,769,762,941.022,769,762,941.023,040,831,719.72
  期末现金及现金等价物余额2,617,212,764.152,891,847,588.942,442,101,919.22,769,762,941.02
补充资料:
  净利润-390,391,575.67-691,896,980.12
  资产减值准备-14,253,517.71-70,302,431.87
  固定资产和投资性房地产折旧-80,569,078.67-172,621,172.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-80,569,078.67-172,621,172.61
  无形资产摊销-9,607,080.96-20,280,374.12
  长期待摊费用摊销-20,812,624.28-42,552,443.89
  处置固定资产、无形资产和其他长期资产的损失-837,997.31--598,273.43
  固定资产报废损失-1,746,428.7-2,106,097.77
  财务费用-2,162,228.93-40,760,144
  投资损失--3,532,052.54--70,823,343.99
  递延所得税-10,758,322.35--7,656,380.46
  其中:递延所得税资产减少-7,675,641.42--6,490,105.65
    递延所得税负债增加-3,082,680.93--1,166,274.81
  存货的减少-260,029,568.79-190,847,556.41
  经营性应收项目的减少--20,700,376.98--615,579,943.98
  经营性应付项目的增加--543,159,247.62--187,554,899.75
  现金的期末余额-2,891,847,588.94-2,769,762,941.02
  减:现金的期初余额-2,769,762,941.02-3,040,831,719.72
  现金及现金等价物的净增加额-122,084,647.92--271,068,778.7
公告日期2025-10-312025-08-292025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑